Assay system for detecting and quantitating cell-free DNA in liquid biopsy samples. Used in prenatal testing and cancer diagnostics with high sensitivity and multiplexing capabilities through the QLoci platform.
Manufactured by
LifeOS Genomics Corporation
Hsinchu City, Taiwan
LifeOS Genomics Corporation is an innovative biotechnology company based in Hsinchu Science Park, Taiwan. LifeOS Genomics is dedicated to the development and commercialization of cutting-edge automated genetic testing instruments and assay reagents that enable routine genetic testing in hospitals and distributed test laboratories. The company is ISO13485:2016 certified and in full compliance with FDA Quality System Regulation (QSR). Bridging the Gap Between PCR and NGS QLoci md1000 Dx Analyzer is based on LifeOS Genomics proprietary Multiplex Digital PCR (mdPCR) technology. It brings about a significant advancement in genetic testing that bridges the gap between research and clinical utility, by providing a platform that can be used for seamlessly translating biomarkers from research into clinical practice. The QLoci md1000 Dx Analyzer provides unique features that open up new possibilities for clinical molecular testing market. Addressing Unmet Needs in Liquid Biopsy The QLoci md1000 Dx Analyzer fills a critical gap between traditional PCR and Next-Generation Sequencing (NGS) by offering unmatched capabilities of addressing unmet needs in liquid biopsy in research and clinical diagnosis. With its unmatched sensitivity and accuracy for clinically relevant biomarkers , our fully automated sample-to-report workflow simplifies the decision-making of medical professionals and researchers in their daily work.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Biopsense Oy
Finland · 3 relevant products
Pilot Gene Technology (Hangzhou) Co., Ltd.
China · 1 relevant product
Intelligenome
United States · 1 relevant product
41 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 63 closest product alternatives
Biopsense Oy · Finland
Blood-based diagnostic test for monitoring cancer treatment efficacy and detecting emerging drug resistance through analysis of circulating tumor DNA. Enables rapid treatment adjustment decisions based on genetic mutation detection in cfDNA.
Pilot Gene Technology (Hangzhou) Co., Ltd. · China
Digital PCR-based assay for detecting single-copy genes and rare mutations in clinical samples. Provides absolute quantification without standard curve requirements.
Intelligenome · United States
CRISPR-based diagnostic assay for oncology applications. Provides molecular detection and monitoring capabilities for cancer-related diagnostics.
60 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products